BCL2 and cancer: STAT3 is regarded as a therapeutic target in many cancers and regulates cyclinD1, c-Myc, Bcl-2, survivin and ICAM-1, related to cell proliferation, survival, migration, invasion, stemness, immunosuppression and angiogenesis [6, 18, 29–31].